Wang H, Liu H, Zhang Y, Chen W
Department of Nephrology, Wuhan First Hospital (Wuhan Hospital of Integrated Traditional Chinese and Western Medicine), Wuhan 430022, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Dec 20;42(12):1839-1845. doi: 10.12122/j.issn.1673-4254.2022.12.12.
To explore the effects of miR-34a on injury and apoptosis of podocytes in diabetic nephropathy (DN) and the role of Notch signaling pathway in mediating its effects.
The expression of miR-34a in podocytes exposed to high glucose (30 mmol/L) was detected using RT-PCR. A podocyte line with miR-34a overexpression was constructed, and the miRNA-target relationship between miR-34a and Notch 1 was verified with luciferase assay. The effects of overexpression of Notch 1 and both miR-34a and Notch 1 on podocyte survival and apoptosis were evaluated using CCK-8 and flow cytometry and by detecting apoptosis-related proteins using Western blotting. In a DN mouse model established by high-fat diet and streptozotocin, the effect of tail vein injection of agomir-34a and agomir-NC on pathology and apoptosis in the renal tissues were observed with HE staining and TUNEL staining, and the renal expressions of apoptosis-related proteins and Notch 1 protein were detected with Western blotting.
High glucose exposure significantly lowered miR-34a expression in cultured human podocytes ( < 0.05). The expression of Notch 1 was significantly lowered in miR-34a-overexpressing podocytes as compared with the cells with miR-NC transfection ( < 0.05). Luciferase assay confirmed the mRNA-target relationship between miR-34a and Notch 1 ( < 0.05). MiR-34a overexpression obviously promoted podocyte survival ( < 0.05), reduced Notch 1 expression, and lowered apoptosis rate and the protein expressions of caspase-3, caspase-9 and Bax/Bcl-2 levels in the cells ( < 0.05), while the reverse changes were observed in Notch 1-overexpressing podocytes ( < 0.05). In DN mouse models, treatment with miR-34a obviously alleviated renal pathologies. Compared with that in the control group, the expression level of miR-34a in the renal tissues was significantly lowered in DN model group ( < 0.05) and increased in miR-34a group ( < 0.05). The mice in the model group showed significantly higher apoptosis index of the renal tissues with increased expressions of caspase-3, caspase-9 and Notch 1 ( < 0.05), which were lowered by treatment with miR-34a ( < 0.05).
MiR-34a is capable of improving podocyte injury and apoptosis in DN mice by targeted downregulation of Notch 1.
探讨微小RNA-34a(miR-34a)对糖尿病肾病(DN)足细胞损伤和凋亡的影响以及Notch信号通路在介导其作用中的作用。
采用逆转录聚合酶链反应(RT-PCR)检测高糖(30 mmol/L)处理的足细胞中miR-34a的表达。构建miR-34a过表达的足细胞系,通过荧光素酶报告基因实验验证miR-34a与Notch 1之间的miRNA-靶标关系。采用细胞计数试剂盒-8(CCK-8)法、流式细胞术以及蛋白质免疫印迹法检测凋亡相关蛋白,评估Notch 1过表达以及miR-34a和Notch 1同时过表达对足细胞存活和凋亡的影响。在高脂饮食联合链脲佐菌素建立的DN小鼠模型中,通过苏木精-伊红(HE)染色和TUNEL染色观察尾静脉注射miR-34a激动剂和阴性对照激动剂对肾组织病理学和凋亡的影响,并用蛋白质免疫印迹法检测肾组织中凋亡相关蛋白和Notch 1蛋白的表达。
高糖处理显著降低了培养的人足细胞中miR-34a的表达(P<0.05)。与转染miR-NC的细胞相比,miR-34a过表达的足细胞中Notch 1的表达显著降低(P<0.05)。荧光素酶报告基因实验证实了miR-34a与Notch 1之间的mRNA-靶标关系(P<0.05)。miR-34a过表达明显促进足细胞存活(P<0.05),降低Notch 1表达,降低细胞凋亡率以及半胱天冬酶-3(caspase-3)、半胱天冬酶-9(caspase-9)和Bax/Bcl-2蛋白的表达水平(P<0.05),而Notch 1过表达的足细胞则出现相反的变化(P<0.05)。在DN小鼠模型中,miR-34a处理明显减轻了肾脏病理改变。与对照组相比,DN模型组肾组织中miR-34a的表达水平显著降低(P<0.05),miR-34a组则升高(P<0.05)。模型组小鼠肾组织凋亡指数显著升高,caspase-3、caspase-9和Notch 1的表达增加(P<0.05),miR-34a处理后这些指标降低(P<0.05)。
miR-34a可通过靶向下调Notch 1改善DN小鼠足细胞损伤和凋亡。